Healthcare Services

Peptide Synthesis Market Developments and Growth Opportunities Across 2026–2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Peptide Synthesis Market Projected To Become By 2030 Based On Its 2026 Valuation?

The peptide synthesis market has shown robust expansion in recent years. It is anticipated to expand from $6.18 billion in 2025 to $6.74 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. This historical growth can be attributed to an increasing demand for peptide-based therapeutics, advancements in solid-phase peptide synthesis, the rise in studies conducted by academic and research institutes, the accessibility of high-purity reagents, and the robust demand from pharmaceutical R&D.

The peptide synthesis market is projected to experience substantial expansion over the coming years, reaching a valuation of $9.91 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This anticipated growth during the forecast period is primarily driven by factors such as the expansion of contract manufacturing and research services, the embrace of hybrid and recombinant peptide technologies, a rise in collaborations between biotechnology and pharmaceutical firms, the growing need for custom peptide synthesis, and progress in peptide characterization and analytical methodologies. Key trends shaping the forecast period encompass the increasing application of AI in peptide design and optimization, the broadening scope of precision medicine applications utilizing peptides, the incorporation of cloud and big data in peptide research, the deployment of IoT-enabled laboratory equipment for continuous monitoring, and the adoption of smart manufacturing practices in peptide production.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13295&type=smp

Which Market Drivers Are Supporting The Expansion Of The Peptide Synthesis Market?

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the peptide synthesis market in the coming years. Chronic diseases, also known as non-communicable diseases (NCDs), are defined as long-standing health issues that continue for prolonged durations and typically develop slowly. Peptide synthesis finds application in chronic diseases because certain peptides possess anti-inflammatory and antioxidant properties, potentially assisting in the prevention of various chronic conditions, such as cardiovascular diseases. Peptides offer new avenues for treatment and management by addressing the underlying causes of chronic diseases through their ability to target specific cellular mechanisms and signaling pathways. For example, reports from the World Health Organization, a specialized agency of the United Nations based in Switzerland, indicated in June 2025 that noncommunicable diseases (NCDs) continue to be the primary contributor to death and disability globally, including within the WHO European Region. In this region, NCDs like cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes are responsible for the deaths of 1 in 5 men and 1 in 10 women before they reach 70 years of age. Consequently, the increasing prevalence of chronic diseases is a significant factor propelling the expansion of the peptide synthesis market.

What Segment Groups Are Identified Within The Peptide Synthesis Market?

The peptide synthesis market covered in this report is segmented –

1) By Product And Service: Reagents, Equipment, Services

2) By Technology: Solid-Phase Peptide Synthesis, Solution-Phase Peptide Synthesis, Hybrid And Recombinant Technology

3) By End User: Pharmaceutical And Biotechnology companies, Contract Manufacturing And Development Organizations (CDMOs) And Contract Research Organizations (CROs), Academic And Research Institutes

Subsegments:

1) By Reagents: Amino Acids, Coupling Reagents, Protecting Groups, Cleavage Reagents

2) By Equipment: Peptide Synthesizers, Chromatography Systems, Mass Spectrometers

3) By Services: Custom Peptide Synthesis, Peptide Characterization And Analysis, Peptide Modification Services, Consulting And Support Services

What Trends Are Projected To Affect The Peptide Synthesis Market?

Leading companies in the peptide synthesis market are concentrating on launching next-generation peptide synthesizers, such as PurePep Sonata+, to achieve a competitive advantage. PurePep Sonata+ is an advanced peptide synthesizer that delivers enhanced efficiency, speed, and accuracy compared to traditional peptide synthesizers. For instance, in August 2025, Vapourtec Ltd, a UK-based company specializing in flow-chemistry instruments, introduced the Peptide-Builder, a compact benchtop peptide synthesizer. The Peptide-Builder expands the capabilities of conventional peptide synthesizers by integrating Vapourtec’s Variable Bed Flow Reactor technology. This innovative approach enables continuous-flow solid-phase peptide synthesis, providing precise control over reaction conditions and allowing high-throughput synthesis of multiple peptide sequences. The system also incorporates automated software for sequence design, optimized coupling/deprotection protocols, and real-time monitoring of resin volume and reaction progress, ensuring accurate and reproducible peptide production across a wide range of sequences and scales.

Which Companies Hold Significant Positions In The Peptide Synthesis Market?

Major companies operating in the peptide synthesis market are Thermo Fisher Scientific, Merck KGaA, Lonza Group, Kaneka Corporation, Guizhou Xinbang Pharmaceutical Co. Ltd., Hybio Pharmaceutical Co. Ltd., GenScript Biotech, Bachem Holding AG, Syngene International, PolyPeptide Group AG, CPC Scientific Inc., New England Peptide Inc., Biotage, ScinoPharm Taiwan Ltd, MP Biomedicals, CEM Corporation, Enamine Ltd., Creative Diagnostics, AnaSpec Inc., CSBio Company Inc., Alfa Chemistry, Advanced ChemTech, Gyros Protein Technologies AB, AAPPTec LLC, Biosynth International Inc., ProteoGenix

Read the full peptide synthesis market report here:

https://www.thebusinessresearchcompany.com/report/peptide-synthesis-global-market-report

How Is The Peptide Synthesis Market Distributed Across Key Geographic Regions?

North America was the largest region in the peptide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peptide synthesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Peptide Synthesis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=13295&type=smp

Browse Through More Reports Similar to the Global Peptide Synthesis Market 2026, By The Business Research Company

Gastric Ulcers Global Market Report

https://www.thebusinessresearchcompany.com/report/gastric-ulcers-global-market-report

Pressure Ulcers Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/pressure-ulcers-treatment-global-market-report

Duodenal Ulcer Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/duodenal-ulcer-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795